Author | Joseph Leach, MD | OncLive

Author | Joseph Leach, MD

Articles

Dr. Leach on Brigatinib in ALK-Positive NSCLC

September 21, 2019

Video

Joseph Leach, MD, medical oncologist at Minnesota Oncology, discusses the use of brigatinib (Alunbrig) in ALK-positive non–small cell lung cancer (NSCLC).

x